Tumor vasculature targeting through NGR peptide-based drugdelivery systems

Angelo Corti, Flavio Curnis

Research output: Contribution to journalArticlepeer-review


Various peptide sequences have been discovered by selecting peptide-phage display libraries in vitro againstspecific receptors or in vivo in tumor-bearing animals. One class of these peptides is characterized by the presence of Asn-Gly-Asp (NGR), a structural motif that can recognize the endothelium and other cells of neoangiogenic vessels. Becauseof this property these peptides have been used by several investigators to deliver a variety of drugs, cytokines, nanoparticles,viruses and imaging agents to tumor blood vessels. Here we review the reports on these conjugates and discuss thestructural, functional and stability properties of NGR embedded into different molecular scaffolds.

Original languageEnglish
Pages (from-to)1128-1134
Number of pages7
JournalCurrent Pharmaceutical Biotechnology
Issue number8
Publication statusPublished - Aug 2011


  • αvβ3 integrin
  • Angiogenesis
  • Asparaginedeamidation
  • CD13
  • Isoaspartate
  • IsoDGR
  • NGR motif
  • Peptide-phage display library
  • Vascular targeting

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Biotechnology


Dive into the research topics of 'Tumor vasculature targeting through NGR peptide-based drugdelivery systems'. Together they form a unique fingerprint.

Cite this